Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis

Oncogene

Volumn 18, Issue 52, 1999, Pages 7423-7431

  Budunova, Irina V ^a   Perez, Paloma ^b   Vaden, Valerie R ^a   Spiegelman, Vladimir S ^a   Slaga, Thomas J ^a   Jorcano, Jose L ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b CIEMAT   (Spain)

Author keywords

I B proteins; NF B factors; Skin carcinogenesis

Indexed keywords

CYTOPLASM PROTEIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION; SKIN; SKIN CARCINOGENESIS; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; THYMOCYTE; TRANSCRIPTION REGULATION;

EID: 0033539885     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203104     Document Type: Article

References (53)

1. Baeuerle PA. (1991). Biochim. Biophys. Acta., 1072, 63-80.
2. Baldwin Jr AS. (1996). Annu. Rev. Immunol., 14, 649-683.
3. Balmain A, Krumlauf R, Vass JK and Birnie GD. (1982). Nucleic Acids Res., 10, 4259-4277.
4. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA and Baldwin Jr AS. (1992). Genes Dev., 6, 1899-1913.
5. Beg AA, Sha WC, Bronson RT and Baltimore D. (1995). Genes Dev., 9, 2736-2746.
6. Binder RL, Johnson GR, Gallagher PM, Stockman SL, Sundberg JP and Conti CJ. (1998). Cancer Res., 58, 4314-4323.
7. Bose Jr HR. (1992). Biochim. Biophys. Acta., 1114, 1-17.
8. Bours V, Dejardin E, Goujon-Letawe F, Merville MP and Castronovo V. (1994). Biochem. Pharmacol., 47, 145-149.
9. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K and Siebenlist U. (1993). Cell, 72, 729-739.
10. Caamano JH, Perez P, Lira SA and Bravo R. (1996). Mol. Cell. Biol., 16, 1342-1348.
11. Carrasco D, Rizzo CA, Dorfman K and Bravo R. (1996). EMBO J., 15, 3640-3650.
12. Collart MA, Baeuerle P and Vassalli P. (1990). Mol. Cell Biol., 10, 1498-1506.
13. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP and Bours V. (1995). Oncogene, 11, 1835-1841.
14. Dobrzanski P, Ryseck RP and Bravo R. (1993). Mol. Cell Biol., 13, 1572-1582.
15. Folgueira L, Algeciras A, MacMorran WS, Bren GD and Paya CV. (1996). J. Virol., 70, 2332-2338.
16. Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi M, Kanno T, Brown K and Siebenlist U. (1993). EMBO J., 12, 3893-3901.
17. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K and Siebenlist U. (1992). Nature, 359, 339-342.
18. Fujita T, Nolan GP, Ghosh S and Baltimore D. (1992). Genes Dev., 6, 775-787.
19. Fujita T, Nolan GP, Liou HC, Scott ML and Baltimore D. (1993). Genes Dev., 7, 1354-1363.
20. Gilmore TD, Koedood M, Piffat KA and White DW. (1996). Oncogene, 13, 1367-1378.
21. Hansen SK, Nerlov C, Zabel U, Verde P, Johnsen M, Baeuerle PA and Blasi F. (1992). EMBO J., 11, 205-213.
22. Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW and Scheidereit C. (1992). Proc. Natl. Acad. Sci. USA, 89, 2489-2493.
23. Inoue J, Kerr LD, Kakizuka A and Verma IM. (1992). Cell, 68, 1109-1120.
24. Inoue J, Takahara T, Akizawa T and Hino O. (1993). Oncogene, 8, 2067-2073.
25. Kang SM, Tran AC, Grilli M and Lenardo MJ. (1992). Science, 256, 1452-1456.
26. Karin M. (1998). Cancer J Sci Am., 4 (Suppl. 1), S92-S99.
27. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, Chen CH, Rosen CA and Stewart CL. (1996). Mol. Cell Biol., 16, 2341-2349.
28. Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P and Giaccia AJ. (1994). Cancer Res., 54, 5273-5279.
29. Kretzschmar M, Meisterernst M, Scheidereit C, Li G and Roeder RG. (1992). Genes Dev., 6, 761-774.
30. Le Bail O, Schmidt-Ullrich R and Israel A. (1993). EMBO J., 12, 5043-5049.
31. Leveillard T and Verma IM. (1993). Gene Expr., 3, 135-150.
32. Lin L, DeMartino GN and Greene WC. (1998). Cell, 92, 819-828.
33. Liptay S, Schmid RM, Nabel EG and Nabel GJ. (1994). Mol. Cell Biol., 14, 7695-7703.
34. Manna SK, Zhang HJ, Yan T, Oberley LW and Aggarwal BB. (1998). J. Biol. Chem., 273, 13245-13254.
35. Matthews JR and Hay RT. (1995). Int. J. Biochem. Cell Biol., 27, 865-879.
36. Mukhopadhyay T, Roth JA and Maxwell SA. (1995). Oncogene, 11, 999-1003.
37. Naumann M, Wulezyn FG and Scheidereit C. (1993). EMBO J., 12, 213-222.
38. Nolan GP, Fujita T, Bhatia K, Huppi C, Liou HC, Scott ML and Baltimore D. (1993). Mol. Cell. Biol., 13, 3557-3566.
39. Plaksin D, Baeuerle PA and Eisenbach L. (1993). J. Exp. Med., 177, 1651-1662.
40. Schmitz ML and Baeuerle PA. (1991). EMBO J., 10, 3805-3817.
41. Schouten GJ, van der Eb AJ and Zantema A. (1995). EMBO J., 14, 1498-1507.
42. Schreiber E, Matthias P, Muller MM and Schaffner W. (1989). Nucleic Acids Res., 17, 6419.
43. Seitz CS, Lin Q, Deng H and Khavari PA. (1998). Proc. Natl. Acad. Sci. USA, 95, 2307-2312.
44. Siebenlist U, Franzoso G and Brown K. (1994). Annu. Rev. Cell Biol., 10, 405-455.
45. Slaga TJ, Budunova IV, Gimenez-Conti IB and Aldaz CM. (1996). J. Investig. Dermatol. Symp. Proc., 1, 151-156.
46. Slaga TJ, DiGiovanni J, Winberg LD and Budunova IV. (1995). Prog. Clin. Biol. Res., 391, 1-20.
47. Sylla BS and Temin HM. (1986). Mol. Cell Biol., 6, 4709-4716.
48. Ten RM, Paya CV, Israel N, Le Bail O, Mattei MG, Virelizier JL, Kourilsky P and Israel A. (1992). EMBO J., 11, 195-203.
49. Tobin D, Nilsson M and Toftgard R. (1996). Oncogene, 12, 785-793.
50. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S and Baeuerle PA. (1995). EMBO J., 14, 2876-2883.
51. Watanabe M, Muramatsu M, Hirai H, Suzuki T, Fujisawa J, Yoshida M, Arai K and Arai N. (1993). Oncogene, 8, 2949-2958.
52. Weih F, Carrasco D and Bravo R. (1994). Oncogene, 9, 3289-3297.
53. Whiteside ST and Israel A. (1997). Semin Cancer Biol., 8, 75-82.